A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation.
Antonio Toesca, Claudia Sangalli, Patrick Maisonneuve...
https://pubmed.ncbi.nlm.nih.gov/34597010Actively Recruiting
Led by Beaumont Hospital · Updated on 2026-06-01
250
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating the differences in patient-reported outcomes between robotic-assisted and conventional open nipple-sparing mastectomy (NSM) in women undergoing immediate breast reconstruction. This trial focuses on women with breast cancer or those at high risk, including genetic mutation carriers and those with ductal carcinoma in situ or early invasive breast cancer. The study aims to determine if the minimally invasive robotic approach offers better cosmetic results, body image, and satisfaction compared to the traditional open surgery. Both implant-based and autologous DIEP flap reconstructions are included to enhance the relevance of the findings. Participants will be randomly assigned to one of two treatment groups within separate reconstruction cohorts. One group receives robotic-assisted NSM using a single-port robotic system through a single axillary incision, performed at a central surgical hub. The other group undergoes standard open NSM through a conventional incision at either local or central sites depending on reconstruction needs. Immediate breast reconstruction follows the assigned NSM technique, either implant-based or DIEP flap. This multicenter study uses a hub-and-spoke model to provide access to robotic surgery while maintaining oncological safety. During the study, participants will be followed for up to 12 months postoperatively. Researchers will collect patient-reported outcomes using validated tools such as the Breast-Q, Hopwood Body Image Scale, and Aesthetic Item Scale to assess satisfaction, body image, and aesthetic results. Blinded assessors will evaluate aesthetic outcomes to reduce bias. Eligibility is carefully determined by clinical and radiological criteria to ensure appropriate candidates for NSM. The study also monitors safety and recovery, aiming to guide future patient care and surgical decision-making in breast cancer treatment.
CONDITIONS
Evaluation of Wellbeing and Patient Reported Outcomes After Open vs Robotic Mastectomy With DIEP Reconstruction
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery day and immediate recovery period
Participants undergo either robotic-assisted or standard open nipple-sparing mastectomy with immediate breast reconstruction using either implant-based or DIEP flap reconstruction.
1 surgical visit (in-person)
Duration - Up to 12 months post operative
Participants are followed after surgery to monitor recovery and assess patient-reported outcomes including wellbeing and aesthetic results.
Multiple follow-up visits up to 12 months
Total: 1 location
1
Beaumont RCSI Cancer Centre
Beaumont, Ireland, D09
Actively Recruiting
T
Trudi Nelson Roche
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Antonio Toesca, Claudia Sangalli, Patrick Maisonneuve...
https://pubmed.ncbi.nlm.nih.gov/34597010